About
Eidos Therapeutics is a clinical-stage biopharmaceutical company focused on developing precision medicines for the treatment of debilitating transthyretin (TTR) amyloidoses.
Explore Eidos Therapeutics, Inc's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.